You are viewing a limited version of this profile. To access i3's full capabilities.
Oxitec
Save
Company logo (jpg or png)
Parent company

Short description

Developer of genetically modified sterile insects enabling environmentally-friendly, species specific biological control for agricultural pests

Founded in 2002
Founded in

Company type Acquired Public ()
Company type

Industry Group agriculture & food

Sector crop inputs

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters United Kingdom Oxford, United Kingdom
Address
City
State
Zip
Country

Parent Companies

Updated by Cleantech Group on 06/30/2022

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
05/31/2012
University of S‹o Paulo University of S‹o Paulo
Oxitec, Moscamed and the University of São Paulo are working together on the development and testing of the dengue vector mosquito, Aedes aegypti.
View source    
Confirmed by University of S‹o Paulo
Development Partner
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
04/13/2022 Bill & Melinda Gates Foundation Bill & Melinda Gates Foundation (1)
Post-money valuation of
The $18M investment has enabled the launch of the next phase of the company's malaria vector program,
Project Finance $18,000,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font